Equasens SA
PAR:EQS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Magni-Tech Industries Bhd
KLSE:MAGNI
|
MY |
|
H
|
Haily Group Bhd
KLSE:HAILY
|
MY |
|
Muthoot Finance Ltd
NSE:MUTHOOTFIN
|
IN |
Equasens SA
Cash
Equasens SA
Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Equasens SA
PAR:EQS
|
Cash
€18.8m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
1%
|
CAGR 10-Years
16%
|
|
|
Cegedim SA
PAR:CGM
|
Cash
€49.6m
|
CAGR 3-Years
27%
|
CAGR 5-Years
11%
|
CAGR 10-Years
2%
|
|
|
Median Technologies SA
PAR:ALMDT
|
Cash
€4.3m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
10%
|
|
Equasens SA
Glance View
Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in the development and integration of management software packages for drugstores. The company offers all IT (Information Technology) and High-Tech fields related to Health and in specialized fields which are associated to it such as IT for pharmacies, solutions for e-Health, solutions for pharmaceutical industry, solutions for patients etc. The firm operates in four divisions that includes Europe Pharmacy Solutions Division including France Pharmacy Section and Belgium and Luxembourg Pharmacy Section, Solutions for sanitary and medico-social entities Division, e-Health Solutions Division including e-Laboratories section, e-Patients section and e-Connect section and Fintech Division.
See Also
What is Equasens SA's Cash?
Cash
18.8m
EUR
Based on the financial report for Jun 30, 2025, Equasens SA's Cash amounts to 18.8m EUR.
What is Equasens SA's Cash growth rate?
Cash CAGR 10Y
16%
Over the last year, the Cash growth was -28%. The average annual Cash growth rates for Equasens SA have been -20% over the past three years , 1% over the past five years , and 16% over the past ten years .
